Reuters logo
FDA places clinical hold on Concert Pharma's hair loss drug
2017年5月17日 / 中午11点46分 / 4 个月前

FDA places clinical hold on Concert Pharma's hair loss drug

May 17 (Reuters) - Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company’s drug to treat alopecia areata, a type of hair loss.

The agency did not cite any concerns about the drug’s safety, Concert Pharma said. (Reporting by Divya Grover in Bengaluru; Editing by Sai Sachin Ravikumar)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below